Abnormalities in expression of genes, mRNA, and proteins of transforming growth factor-beta receptor type I and type II in human pituitary adenomas.
Abnormalities in the expression of the deoxyribonucleic acid (DNA), messenger ribonucleic acid (mRNA), and proteins of transforming growth factor-beta (TGF-beta) receptor type I (T beta R-I) and TGF-beta receptor type II (T beta R-II) were investigated in 33 human pituitary adenomas. mRNA was extracted from the tumor tissue, and complementary DNA was produced by reverse transcription-polymerase chain reaction (RT-PCR). DNA abnormalities were screened by the PCR method and single-strand conformation polymorphism (SSCP) analysis. Direct sequencing was performed on regions suspected to be abnormal by SSCP (n = 28). The expression of mRNA was measured by quantitative PCR. The expression of T beta R-I and T beta R-II proteins were quantified by immunohistochemical staining. mRNA expression was compared with that of protein expression (n = 22). No gene mutation was detected, but one base substitution in the part of serine/threonine kinase domain of T beta R-II gene (codon 389) was found in 10 of 28 cases examined. Case 2 and case 8 of these 10 cases showed homozygous and heterozygous polymorphism, respectively. The expression of T beta R-I and T beta R-II differed at the protein level between tumors, and was significantly correlated with the expression at the mRNA level. Such differences in the expression of T beta R-I and/or T beta R-II mRNA in pituitary tumors may affect the growth control mediated by TGF-beta, and may indicate the bioactivity of pituitary tumor. Differences in the expression of T beta R-I and/or T beta R-II mRNA are attributable to an abnormality at the transcriptional level.